Pictet North America Advisors’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.13M Sell
171,927
-721
-0.4% -$39K 0.8% 38
2026
Q1
$9.35M Buy
172,648
+1,389
+0.8% +$79.6K 0.93% 33
2025
Q4
$9.42M Buy
171,259
+2,309
+1% +$118K 0.89% 33
2025
Q3
$8.15M Sell
168,950
-404
-0.2% -$20.6K 0.76% 35
2025
Q2
$8.42M Buy
+169,354
New +$8.54M 0.85% 34

Other funds holding AMRZ

Pictet North America Advisors's AMRZ Position: Q2 2026 in Review

Pictet North America Advisors reduced its Amrize Ltd (AMRZ) stake by 0.42% in Q2 2026, selling an estimated $39K and leaving 171,927 shares worth $9.13M. The position accounts for 0.8% of the portfolio, ranked #38.

Pictet North America Advisors first reported a position in AMRZ in Q2 2025 and has held it in 5 quarters since. The position peaked at $9.42M in Q4 2025. 465 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

  • Pictet North America Advisors held 171,927 shares of Amrize Ltd worth $9.13M as of Q2 2026.
  • Pictet North America Advisors sold 721 Amrize Ltd shares in Q2 2026, an estimated $39K.
  • Amrize Ltd made up 0.8% of Pictet North America Advisors's portfolio in Q2 2026, its #38 holding.
  • Pictet North America Advisors first reported a position in Amrize Ltd in Q2 2025 and has held it in 5 quarters since.
  • Pictet North America Advisors's Amrize Ltd position peaked at $9.42M in Q4 2025.
  • 465 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Pictet North America Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.